KMDS
E-submission
Search
- Page Path
- HOME > Search
Brief communication
- Accessibility of Device-Aided Therapies for Persons With Parkinson’s Disease in Poland
- Katarzyna Smilowska, Tomasz Pietrzykowski, K. Ray Chaudhuri, Bastiaan R. Bloem, Daniel J. van Wamelen
- J Mov Disord. 2024;17(2):208-212. Published online November 20, 2023
- DOI: https://doi.org/10.14802/jmd.23172
- 7,440 View
- 126 Download
- 8 Web of Science
- 9 Crossref
-
Abstract
PDF
Supplementary Material - Objective
Access to care for people with Parkinson’s disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation, intraduodenal levodopa pump therapy, and apomorphine pump therapy) in Poland.
Methods
We analyzed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015–2021.
Results
In 2021, the number of persons receiving DAT in Poland was 0.56% of the total PD population, increasing from 0.21% in 2015. Overall, deep brain stimulation was the preferred DAT in Poland, but strong regional differences in the use of the other DATs were observed. Accessibility to DAT was negatively associated with average annual income (p < 0.001).
Conclusion
Access to DAT for persons with PD in Poland is still limited, and strong regional differences in accessibility were observed, although its general increase over the last decade is encouraging. -
Citations
Citations to this article as recorded by
- Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study
Diego Santos‐García, Ángela Solleiro, Guillermo González‐Ortega, Pablo Mir, Nuria López‐Ariztegui, Rocío García Ramos, Inés Legarda, Anna Planas‐Ballvé, Deborah Alonso‐Modino, Pilar Sánchez‐Alonso, Iria Cabo, Marta Blázquez‐Estrada, Álvaro Sánchez‐Ferro
Movement Disorders Clinical Practice.2026; 13(1): 154. CrossRef - Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches
Martin Regensburger, Ilona Csoti, Wolfgang H. Jost, Zacharias Kohl, Stefan Lorenzl, David J. Pedrosa, Paul Lingor
Journal of Neural Transmission.2026; 133(2): 309. CrossRef - Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report
Norlinah Mohamed Ibrahim, Warongporn Phuenpathom, Priya Jagota, Roongroj Bhidayasiri, Pramod Kumar Pal, Chin‐Hsien Lin, Prashanth Lingappa Kukkle, Taku Hatano, Shen‐Yang Lim, Zhanybek Myrzayev, HuiFang Shang, Jed Noel Ong, Raymond L. Rosales, Jinyoung You
Movement Disorders Clinical Practice.2026; 13(2): 379. CrossRef - Six-month outcomes of subcutaneous foslevodopa/foscarbidopa according to initiation setting in advanced Parkinson's disease: A retrospective cohort study
C. Desjardins, H. de Saint Vaulry, C. Rosset, Q. Salardaine, J.-P. Brandel, G. Baille
Revue Neurologique.2026; 182(7): 615. CrossRef - Levodopa–entacapone–carbidopa intestinal gel in advanced Parkinson’s disease: an analysis of interim data for Romanian patients enrolled in the ELEGANCE study
József Attila Szász, Alina Vasilica Blesneag, Traian Flavius Dan, Viorelia Adelina Constantin, Dafin Fior Mureşanu, Dragoş Cătălin Jianu, Any Axelerad, Delia Tulbă, Bogdan Ovidiu Popescu
Journal of Neural Transmission.2026;[Epub] CrossRef - Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson’s disease: insights from the French National Healthcare Data System (2015–2021)
Manon Auffret, Emmanuel Nowak, Marc Vérin, Sandrine Kerbrat
BMJ Neurology Open.2026; 8(1): e001577. CrossRef - Regional features in the treatment of Parkinson’s disease in the Baltic States compared to Germany
Paula Abola, Ligita Smeltere, Ruta Kaladyte Lokominiene, Georg Straeten, Karlheinz Reinfrank, Katrin Sikk, Pille Taba
BMC Health Services Research.2026;[Epub] CrossRef - Defining ‘OFF’ time in device-aided therapy criteria for Parkinson’s disease: gaps and opportunities
Roongroj Bhidayasiri, Phooi Leng Lean, K. Ray Chaudhuri
Parkinsonism & Related Disorders.2025; 139: 107894. CrossRef - Selection of patients with Parkinson’s disease for interventional therapies: A review of available tools — scales and questionnaires
E.V. Bril, E.N. Antyukhova, A.A. Tomskiy, A.A. Gamaleya, N.V. Fedorova
S.S. Korsakov Journal of Neurology and Psychiatry.2025; 125(11): 11. CrossRef
- Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study
First
Prev
